Teva Pharmaceuticals has agreed to pay $450 million to resolve claims of violating the Anti-Kickback Statute. The company engaged in schemes to manipulate drug prices, including paying copays for its multiple sclerosis drug and fixing prices for other generic drugs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing